1. Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.
- Author
-
Liu F, Huang J, and Sadler JE
- Subjects
- Animals, Calcium metabolism, Cyclic AMP-Dependent Protein Kinases antagonists & inhibitors, Cyclic AMP-Dependent Protein Kinases metabolism, Diarrhea microbiology, Diarrhea pathology, Egtazic Acid analogs & derivatives, Egtazic Acid metabolism, Endothelial Cells cytology, Endothelial Cells drug effects, Escherichia coli chemistry, Escherichia coli metabolism, Escherichia coli Infections microbiology, Escherichia coli Infections pathology, Gene Silencing drug effects, Hemolytic-Uremic Syndrome microbiology, Hemolytic-Uremic Syndrome pathology, Humans, Mice, Protein Binding, Protein Kinase C-alpha antagonists & inhibitors, Protein Kinase C-alpha metabolism, Protein Kinase Inhibitors pharmacology, RNA, Small Interfering pharmacology, Trihexosylceramides metabolism, Umbilical Veins cytology, Diarrhea metabolism, Endothelial Cells metabolism, Escherichia coli Infections metabolism, Hemolytic-Uremic Syndrome metabolism, Shiga Toxin 1 adverse effects, Shiga Toxin 1 pharmacology, Shiga Toxin 2 adverse effects, Shiga Toxin 2 pharmacology, Signal Transduction drug effects, von Willebrand Factor metabolism
- Abstract
Diarrhea-associated hemolytic uremic syndrome (D(+)HUS) is caused by the ingestion of Escherichia coli that produce Shiga toxin (Stx), which is composed of a cytotoxic A subunit and pentameric B subunits that bind globotriaosylceramide on susceptible cells. Stx occurs in 2 types, Stx1 and Stx2. B subunits of either type stimulate von Willebrand factor (VWF) secretion from human umbilical vein endothelial cells (HUVECs), and Stx2B can cause thrombotic microangiopathy in Adamts13(-/-) mice. We have now determined that Stx1B and Stx2B activate different signaling pathways in HUVECs. VWF secretion induced by Stx1B is associated with a transient rise in intracellular Ca(2+) level that is blocked by chelation with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester, removal of extracellular Ca(2+), the phospholipase C inhibitor U73122, the protein kinase inhibitor staurosporine, or small interfering RNA knockdown of protein kinase Cα. In contrast, Stx2B-induced VWF secretion is associated with activation of protein kinase A (PKA) and is blocked by the PKA inhibitor H89 or small interfering RNA knockdown of PKA. Stx2B does not increase cAMP levels and may activate PKA by a cAMP-independent mechanism. The activation of distinct signaling pathways may be relevant to understanding why E coli that express Stx2 are more likely to cause D(+)HUS than are E coli expressing only Stx1.
- Published
- 2011
- Full Text
- View/download PDF